|
COPYRIGHT 2006 International Medical News Group
BALTIMORE -- There is little evidence to support a genuine benefit from drug therapy for patients with Alzheimer's disease, Dr. Thomas Finucane said at a meeting sponsored by the American Geriatrics Society and Johns Hopkins University.
Families of patients with Alzheimer's disease (AD) often think of drug treatment first, but cholinesterase inhibitors--the drugs most often recommended for AD--do not benefit the daily lives of most patients, said Dr. Finucane, a professor in the division of geriatric medicine and gerontology at Johns Hopkins University, Baltimore.
When family members or other caregivers insist on trying drug therapy, despite the expense and the potential side effects, propose an end point for drug use, at which time the patient will discontinue the drug...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
